Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 532

1.

Efficacy and tolerability of a medicinal product containing an isopropanolic black cohosh extract in Chinese women with menopausal symptoms: a randomized, double blind, parallel-controlled study versus tibolone.

Bai W, Henneicke-von Zepelin HH, Wang S, Zheng S, Liu J, Zhang Z, Geng L, Hu L, Jiao C, Liske E.

Maturitas. 2007 Sep 20;58(1):31-41. Epub 2007 Jun 22.

PMID:
17587516
2.

[Efficacy and safety of remifemin compared to tibolone for controlling of perimenopausal symptoms].

Bai WP, Wang SY, Liu JL, Geng L, Hu LN, Zhang ZL, Chen SL, Zheng SR.

Zhonghua Fu Chan Ke Za Zhi. 2009 Aug;44(8):597-600. Chinese.

PMID:
20003788
3.

Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms.

Osmers R, Friede M, Liske E, Schnitker J, Freudenstein J, Henneicke-von Zepelin HH.

Obstet Gynecol. 2005 May;105(5 Pt 1):1074-83. Erratum in: Obstet Gynecol. 2005 Sep;106(3):644.

PMID:
15863547
4.

Cimicifuga racemosa dried ethanolic extract in menopausal disorders: a double-blind placebo-controlled clinical trial.

Frei-Kleiner S, Schaffner W, Rahlfs VW, Bodmer Ch, Birkhäuser M.

Maturitas. 2005 Aug 16;51(4):397-404. Epub 2004 Dec 10.

PMID:
16039414
6.

Tibolone and low-dose continuous combined hormone treatment: vaginal bleeding pattern, efficacy and tolerability.

Hammar ML, van de Weijer P, Franke HR, Pornel B, von Mauw EM, Nijland EA; TOTAL Study Investigators Group.

BJOG. 2007 Dec;114(12):1522-9.

7.

Randomized placebo- and active-controlled study of desvenlafaxine for menopausal vasomotor symptoms.

Bouchard P, Panay N, de Villiers TJ, Vincendon P, Bao W, Cheng RJ, Constantine G.

Climacteric. 2012 Feb;15(1):12-20. doi: 10.3109/13697137.2011.586445. Epub 2011 Nov 8.

PMID:
22066790
9.

Efficacy and safety of oral tibolone 1.25 or 2.5 mg/day vs. placebo in postmenopausal women.

Hudita D, Posea C, Ceausu I, Rusu M.

Eur Rev Med Pharmacol Sci. 2003 Sep-Oct;7(5):117-25.

PMID:
15214586
10.

Dose-response analysis of effects of tibolone on climacteric symptoms.

Landgren MB, Bennink HJ, Helmond FA, Engelen S.

BJOG. 2002 Oct;109(10):1109-14.

11.

Safety and efficacy of tibolone and menopausal transition: a randomized, double-blind placebo-controlled trial.

Morais-Socorro M, Cavalcanti MA, Martins R, Neto Francisco P, Rezende A, Azevedo G, Almeida M.

Gynecol Endocrinol. 2012 Jun;28(6):483-7. doi: 10.3109/09513590.2011.634937. Epub 2011 Dec 1.

PMID:
22132809
12.

The safety of black cohosh (Actaea racemosa, Cimicifuga racemosa).

Huntley A.

Expert Opin Drug Saf. 2004 Nov;3(6):615-23. Review.

PMID:
15500420
13.

Efficacy of Cimicifuga racemosa on climacteric complaints: a randomized study versus low-dose transdermal estradiol.

Nappi RE, Malavasi B, Brundu B, Facchinetti F.

Gynecol Endocrinol. 2005 Jan;20(1):30-5.

PMID:
15969244
14.
15.
16.

Black cohosh and St. John's wort for climacteric complaints: a randomized trial.

Uebelhack R, Blohmer JU, Graubaum HJ, Busch R, Gruenwald J, Wernecke KD.

Obstet Gynecol. 2006 Feb;107(2 Pt 1):247-55.

PMID:
16449108
17.

Effect of Isopropanolic Cimicifuga racemosa Extract on Uterine Fibroids in Comparison with Tibolone among Patients of a Recent Randomized, Double Blind, Parallel-Controlled Study in Chinese Women with Menopausal Symptoms.

Xi S, Liske E, Wang S, Liu J, Zhang Z, Geng L, Hu L, Jiao C, Zheng S, Zepelin HH, Bai W.

Evid Based Complement Alternat Med. 2014;2014:717686. doi: 10.1155/2014/717686. Epub 2014 Mar 2.

18.

Menopause: a standardized isopropanolic black cohosh extract (remifemin) is found to be safe and effective for menopausal symptoms.

Ross SM.

Holist Nurs Pract. 2012 Jan-Feb;26(1):58-61. doi: 10.1097/HNP.0b013e31823d1f67.

PMID:
22157510
19.

Supplemental Content

Support Center